Wende Hutton is a General Partner at Canaan, where her bio states she identifies, builds and invests in companies bringing novel drugs, technologies and devices to market. She joined Canaan in 2004 after starting her venture career as a General Partner at Mayfield and holding senior marketing roles at GenPharm and Nellcor. Canaan lists Antiva Biosciences, Glooko, Hyalex Orthopaedics and Qlaris Bio among her current investments, and Chimerix, Dermira, Labrys Biologics and Transcend Medical among her previous ones. She holds an A.B. in human biology from Stanford University and an M.B.A. from Harvard Business School.